These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Saint-Mezard P; Berthier CC; Zhang H; Hertig A; Kaiser S; Schumacher M; Wieczorek G; Bigaud M; Kehren J; Rondeau E; Raulf F; Marti HP Transpl Int; 2009 Mar; 22(3):293-302. PubMed ID: 19017305 [TBL] [Abstract][Full Text] [Related]
10. Apoptotic tubular cell death during acute renal allograft rejection. Wever PC; Aten J; Rentenaar RJ; Hack CE; Koopman G; Weening JJ; ten Berge IJ Clin Nephrol; 1998 Jan; 49(1):28-34. PubMed ID: 9491283 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of early diagnose and treatment of subclinical renal allograft rejection]. Zeng JH; Yu LX; Luo HH; Wang XC; Wang X; Fang W Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):697-8. PubMed ID: 16762888 [TBL] [Abstract][Full Text] [Related]
12. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival. Hariharan S; Alexander JW; Schroeder TJ; First MR Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775 [TBL] [Abstract][Full Text] [Related]
13. Acute rejection in non-compliant renal allograft recipients: a distinct morphology. Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383 [TBL] [Abstract][Full Text] [Related]
15. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection. Brook NR; White SA; Waller JR; Bicknell GR; Nicholson ML Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effect. Kuypers DR Transplantation; 2008 Apr; 85(7 Suppl):S25-30. PubMed ID: 18401259 [TBL] [Abstract][Full Text] [Related]
17. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection? Azarpira N; Aghdaie MH; Malekpour Z Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689 [TBL] [Abstract][Full Text] [Related]
18. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708 [TBL] [Abstract][Full Text] [Related]
19. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF; Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398 [TBL] [Abstract][Full Text] [Related]
20. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients. Kuypers DR; Vanrenterghem Y Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]